Alpha Tau Medical (DRTS) Beginning Cash Balance (2021 - 2022)

Alpha Tau Medical's (DRTS) quarterly Beginning Cash Balance came in at $23.9 million in Q1 2022, up 47.48% year-on-year from $16.2 million in Q1 2021, and up 47.48% quarter-over-quarter from $16.2 million in Q1 2021.

Alpha Tau Medical (DRTS) Beginning Cash Balance (2021 - 2022) Analysis & Trends

Alpha Tau Medical has disclosed Beginning Cash Balance across 2 years of filings, most recently posting $23.9 million for Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Alpha Tau Medical 2,416.70 -76.42 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 23.85 Mn
Mar 31, 2022 23.85 Mn
Mar 31, 2021 16.17 Mn
Mar 31, 2021 16.17 Mn